Lv1
58 积分 2024-01-04 加入
Axicabtagene ciloleucel in relapsed or refractory indolent non-Hodgkin lymphoma (ZUMA-5): a single-arm, multicentre, phase 2 trial
3天前
已完结
Patient‐reported outcomes (PROs) in chronic urticaria
9天前
已完结
Trustworthy Patient-Centered Guidelines: Insights From Atopic Dermatitis and a Proposal for the Future
28天前
已关闭
International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma
1个月前
已完结
Expert consensus on diagnosis and treatment of chronic inducible urticaria in China （2023）
2个月前
已完结
Guideline for diagnosis and treatment of urticaria in China （2022）
2个月前
已完结
A β-1,3/1,6-glucan enhances anti-tumor effects of PD1 antibody by reprogramming tumor microenvironment
2个月前
已关闭
β-Glucan–conjugated anti–PD-L1 antibody enhances antitumor efficacy in preclinical mouse models
2个月前
已完结
Long-Term Safety and Curvature Deformity Characterization in Patients Previously Treated with Collagenase clostridium Histolyticum for Peyronie’s Disease
2个月前
已完结
Incidence of community-acquired pneumonia in urban China: A national population-based study
2个月前
已完结
皖公网安备34019202002308
